The North America hospital acquired infections diagnostics market is expected to witness significant growth due to the high prevalence of hospital-acquired infections in the region. The U.S. and Canada are expected to be major contributors to the market growth.
Asia Pacific:
The Asia Pacific hospital acquired infections diagnostics market is anticipated to experience rapid growth, particularly in countries like China, Japan, and South Korea. The increasing awareness about the importance of infection control measures is expected to drive market growth in the region.
Europe:
Europe is expected to be a lucrative market for hospital acquired infections diagnostics, with the United Kingdom, Germany, and France leading the way. The presence of well-established healthcare infrastructure and the increasing focus on patient safety are expected to drive market growth in these countries.